Sensex falls 143 pts, Nifty below 19,400; RIL, Infosys weigh, M&M gains 4%

Closing Bell on November 9, 2023: In the broader markets, the BSE MidCap index added 0.06 per cent, but the BSE SmallCap index slipped 0.27 per cent

2:27 PM

ALERT:: Adani Ports Q2 net grows 14%; stock slips 2%

Adani Ports & Special Economic Zones today reported a 13.9 per cent growth in Q2FY24 consolidated net at Rs 2,031 crore when compared with Rs 1,783 crore in Q2FY23. Total income grew 32.7 per cent YoY to Rs 7,654 crore.

2:16 PM

ALERT:: Samvardhana Motherson Q2 net rises 2%; stock down 0.5%

Samvardhana Motherson International today reported a 2.1 per cent rise in Q2FY24 consolidated net at Rs 294.15 crore when compared with Rs 288.20 crore in Q2FY23. Total income grew 28.8 per cent YoY to Rs 23,639.16 crore.

2:06 PM

ArcelorMittal SA's Q3 profit drops as steel market demand weakens

"The company remains positive on the medium/long-term steel demand outlook," ArcelorMittal said in a statement on Thursday. READ MORE

1:55 PM

ALERT:: Electrosteel Castings Q2 net soars 3-fold; stock up 2%

Electrosteel Castings today reported a 187.9 per cent growth in Q2FY24 net profit at Rs 184.05 crore when compared with Rs 63.93 crore in Q2FY23. Total income increased 9.4 per cent YoY to Rs 1,888.24 crore.

1:42 PM

SoftBank Group's vision fund reports another loss of $1.7 bn

SoftBank Group Corp.’s flagship Vision Fund reported another loss as valuations on some of its bets declined, even as the investor chases new deals in AI. READ MORE

: 

1:31 PM

ALERT:: Mukand Q2 consolidated net soars 10-fold; stock up 2%

Mukand today reported a 871.3 per cent surge in Q2FY24 consolidated net profit at Rs 23.31 crore when compared with Rs 2.40 crore in Q2FY23. Total income, however, was down 7 per cent YoY at Rs 1,380.16 crore.

1:21 PM

ALERT:: Granules India Q2 net rises 7%; stock marginally down

Granules India today reported a 6.6 per cent growth in Q2FY24 net profit at Rs 116.16 crore when compared with Rs 108.93 crore in Q2FY23. Total income was up 4.5 per cent YoY at Rs 1,010.67 crore.

1:09 PM

JSW Steel's production grows 12% to 2.32 million tonnes in October

JSW Steel on Thursday announced that consolidated crude steel production for October stood at 2.32 million tonnes, growing by 12 per cent year-on-year (y-o-y).

Capacity utilisation at the level of Indian operations was recorded at 95 per cent for October. The company said in a press release that JSW Steel USA-Ohio volumes were positively impacted due to improved demand compared to last year. Read

12:57 PM

India vulnerable to recurring, overlapping food price shocks: RBI Guv Das

India's retail inflation eased to a three-month low of 5.02 per cent in September on the back of softer vegetable prices, but remained above the RBI's 4 per cent target. Read

12:45 PM

Samvat 2080: Stock picks by HDFC Sec, Kotak Sec, ICICI Direct, JM Financial

Here's a list of Diwali picks recommended by top brokerage and research firms that can help you build your portfolio for Samvat 2080. Read

12:34 PM

HC orders tax refund of Rs 1,128 cr to Vodafone Idea; pulls up I-T dept

The Bombay High Court has directed the Income Tax department to refund Rs 1,128 crore to Vodafone Idea Limited paid by the telecom operator in taxes for the assessment year 2016-2017. Read

12:20 PM

Samvat 2079: Mid, Small-cap indices set to post 2nd best show in 9 years

As many as 497, or half of 1050 stocks, from the midcap and smallcap index have outperformed the all benchmark indices and appreciated over 35 per cent during Samvat 2079. Read

12:05 PM

Lupin's net profit jumps nearly four-fold on strong US growth, stock up

Mumbai-based pharmaceutical firm Lupin reported a net profit of Rs 489.7 crore for the quarter – a jump of almost four-times from Rs 129.7 crore in the same period last year. Read

11:50 AM

Piramal Pharma jumps 4% on receiving FDA EIR report for US unit

Company has received establishment inspection report (EIR) from US FDA for its Bethlehem unit in the US, indicating closure of the inspection. 

11:38 AM

Eris up 8% as it plans to acquire nephro, derma units of Biocon Biologics

The deal consideration is Rs 366 crore inclusive of working capital, and will be funded partly through debt financing. Read